FENNEC PHARMACEUTICALS INC. Balance Sheet
FENC|12 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$71M
FY2025
Cash
$37M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
-$6M
FY2025
FENNEC PHARMACEUTICALS INC. had $71M in total assets with negative shareholders' equity of $6M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36.8M | $26.6M | $13.3M | $21.1M | $22.8M | $28.3M | $3.9M | $942.0K | $2.3M | $1.7M | $0 | $0 |
| Current Assets | $67.0M | $44.1M | $26.9M | $22.4M | $13.9M | - | - | - | - | - | - | - |
| Total Assets | $70.6M | $44.9M | $26.9M | $22.4M | $14.1M | $22.9M | $28.4M | $4.0M | $1.0M | $2.4M | $1.8M | $2.4M |
| Current Liabilities | $10.5M | $6.9M | $7.6M | $1.7M | $2.3M | $1.6M | $1.6M | $402.0K | $471.0K | $1.8M | $3.2M | $7.3M |
| Shareholders' Equity | -$5.9M | -$11.6M | -$2.6M | $29.1M | $21.3M | $26.8M | $3.6M | $548.0K | $613.0K | -$5.0M | $0 | $0 |